Fundraising Fox

Ablative Solutions

Wakefield, US · Founded 2011 · Delaware corporation · 4 known investors

Healthtech

Founders & leadership

Ablative Solutions was founded in 2011 by Tim A. Fischell.

TA
Tim A. FischellFounder
KR
Kate RumrillExecutive
LM
Lisa MastromatteiExecutive
RD
Ronald D BacheExecutive
VE
Vartan E. GhazarossianExecutive
VG
Vartan GhazarossianExecutive
DR
David R. FischellNamed on SEC filing

Board

LC
Louis CannonBoard director
GP
Geoff PardoBoard director
NH
Nathan HarringtonBoard director
JK
John KerschenBoard director
DGDale Grogan
Dale GroganinBoard directorManaging Partner at Michigan Capital Network

Investors · 4

Michigan Capital NetworkGrand Rapids
BioStar VenturesreportedPetoskey
Gilde HealthcarereportedUtrecht · $1.1M – $55M
MAFreportedGrand Rapids

Reported raises · per SEC filings

Form D private placements

$166.9M disclosed across 12 rounds · 2011–2025

▶$10.4MraisedNov 2025 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald D. BacheExecutive Officer, Director
  • Louis CannonDirector
  • John KerschenDirector
  • Geoff PardoDirector
  • Brian RaulsExecutive Officer
  • Benjamin TsaiDirector
Offering amount
$45M
Amount sold
$10.4M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.2MraisedDec 2024 · 88 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kate RumrillExecutive Officer, Director
  • Lisa MastromatteiExecutive Officer
  • David R FischellDirector
  • Louis CannonDirector
  • Geoff PardoDirector
  • Paul BuckmanDirector
  • Ronald D BacheExecutive Officer, Director
  • Nathan HarringtonDirector
  • John KerschenDirector
Offering amount
$45.5M
Amount sold
$37.2M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.3MraisedJan 2024 · 121 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael FultonDirector
  • Paul BuckmanDirector
  • David R. FischellDirector
  • John KerschenDirector
  • Andrew TochtermanDirector
  • Kate RumrillExecutive Officer, Director
  • Lisa MastromatteiExecutive Officer
  • Geoff PardoDirector
  • Ronald D. BacheDirector
Offering amount
$30M
Amount sold
$29.3M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$54.5MraisedFeb 2021 · 105 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David R. FischellDirector
  • John KerschenDirector
  • Paul BuckmanDirector
  • Geoff PardoDirector
  • Andrew TochtermanDirector
  • Kate RumrillExecutive Officer, Director
  • Lisa MastromatteiExecutive Officer
  • Michael FultonDirector
Offering amount
$91.5M
Amount sold
$54.5M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJan 2018 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Phillip D. TorrenceExecutive Officer
  • Nicole HarataniExecutive Officer
  • Steven L. AlmanyDirector
  • Dale GroganDirector
  • Paul BuckmanDirector
  • Tim A. FischellExecutive Officer, Director
  • David R. FischellExecutive Officer, Director
Offering amount
$10M
Amount sold
$4M
Minimum investment
$10K
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.4MraisedMar 2017 · 88 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicole HarataniExecutive Officer
  • Phillip D. TorrenceExecutive Officer
  • Paul BuckmanDirector
  • David R. FischellExecutive Officer, Director
  • Steven L. AlmanyDirector
  • Dale GroganDirector
  • Tim A. FischellExecutive Officer, Director
Offering amount
$15.8M
Amount sold
$11.4M
Minimum investment
$25K
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedNov 2015 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dale GroganDirector
  • David K. RosenDirector
  • Tim A. FischellExecutive Officer, Director
  • Phillip D. TorrenceExecutive Officer
  • Vartan E. GhazarossianExecutive Officer, Director
  • Steven L. AlmanyDirector
  • David R. FischellExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$2.5M
Minimum investment
$25K
Proceeds to insiders
$25K
First sale
Oct 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.6MraisedJan 2015 · 149 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dale GroganDirector
  • Steven L. AlmanyDirector
  • David K. RosenDirector
  • Vartan E. GhazarossianExecutive Officer, Director
  • Tim A. FischellExecutive Officer, Director
  • David R. FischellExecutive Officer, Director
  • Phillip D. TorrenceExecutive Officer
Offering amount
$18M
Amount sold
$14.6M
Proceeds to insiders
$375K
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Rf Surgical3 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Companies competing with Ablative Solutions for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Ablative Solutions raises $91.4M in Series D financing round | MDmassdevice.com · Jun 2022Is Ablative Solutions’ Latest Financing a Positive Sign for Renal Demddionline.com · Jan 2019Ablative Solutions closes $77m Series D - MassDevicemassdevice.com · Jan 2019Ablative Solutions, Inc. Announces $77 Million Financing for Unique Therapeutic Approach to Treating Uncontrolled Hypertension - BioSpacebiospace.com · Jan 2019Ablative Solutions Raises $77M Financing Round - FinSMEsfinsmes.com · Jan 2019Clinical-stage company raises $9.5M in funding | Crain's Grand Rapids Businesscrainsgrandrapids.com · Feb 2014

Frequently asked questions

Who founded Ablative Solutions?
Ablative Solutions was founded by Tim A. Fischell in 2011.
Who are Ablative Solutions's investors?
Ablative Solutions's investors include Michigan Capital Network, BioStar Ventures, Gilde Healthcare, MAF.
How much funding has Ablative Solutions raised?
Ablative Solutions has disclosed $166.9M raised across 12 rounds.
Where is Ablative Solutions headquartered?
Ablative Solutions is headquartered in Wakefield, US.